Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005–2022

BACKGROUND: Glioblastoma is the most aggressive primary brain cancer with a poor prognosis. Despite numerous studies in the past 17 years, effective treatment options for glioblastoma remain limited. In this study, we aimed to identify and compare phase III clinical trials for glioblastoma in terms...

Descripción completa

Detalles Bibliográficos
Autores principales: Oster, Christoph, Schmidt, Teresa, Agkatsev, Sarina, Lazaridis, Lazaros, Kleinschnitz, Christoph, Sure, Ulrich, Scheffler, Björn, Kebir, Sied, Glas, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558397/
https://www.ncbi.nlm.nih.gov/pubmed/37811538
http://dx.doi.org/10.1093/noajnl/vdad105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558397/
https://www.ncbi.nlm.nih.gov/pubmed/37811538
http://dx.doi.org/10.1093/noajnl/vdad105

Ejemplares similares